[Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants].
D001991:Bronchitis; D002086:Butylscopolammonium Bromide; D002648:Child; D006801:Humans; D007223:Infant; D009128:Muscle Spasticity; D010276:Parasympatholytics; D012602:Scopolamine Derivatives
D010276:Parasympatholytics; D012602:Scopolamine Derivatives; D002086:Butylscopolammonium Bromide
BRONCHITIS/in infant and child; SCOPOLAMINE/derivatives
Uber den klinischen Effekt des spasmolytisch wirksamen Hyoscinn-butylbromid (Buscopan) bei der sogenannten spastischen Bronchitis des Säuglings.